Cleft lip/palate-intestinal malrotation-cardiopathy syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2001OMIM:601165Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Cleft lip/palate-intestinal malrotation-cardiopathy syndrome (also known as Toriello-Carey syndrome) is an extremely rare congenital malformation syndrome characterized by the combination of orofacial clefting, intestinal malrotation, and cardiac defects. The condition is typically apparent at birth and affects multiple organ systems. Key clinical features include cleft lip and/or cleft palate, malrotation of the intestines (abnormal positioning of the bowel that can lead to obstruction), and congenital heart defects of variable type and severity. Additional features that have been reported in affected individuals include Robin sequence (micrognathia, glossoptosis, and cleft palate), laryngeal and subglottic abnormalities, central nervous system anomalies such as agenesis of the corpus callosum, and intellectual disability. Some patients may also present with hypotonia and short stature. The syndrome was first described by Toriello and Carey, and only a small number of cases have been reported in the medical literature, making it difficult to fully delineate the clinical spectrum. The prognosis depends largely on the severity of the cardiac and gastrointestinal malformations. Treatment is supportive and symptom-based, typically requiring a multidisciplinary approach. Surgical intervention is often necessary for the cleft lip/palate repair, correction of intestinal malrotation (Ladd procedure), and repair of congenital heart defects. Ongoing monitoring by specialists in cardiology, gastroenterology, genetics, and developmental pediatrics is recommended. There is no specific cure or targeted therapy for this syndrome, and management focuses on addressing individual malformations and optimizing developmental outcomes.

Also known as:

Clinical phenotype terms— hover any for plain English:

Flat occiputHP:0005469Abnormal aortic morphologyHP:0001679Bifid tongueHP:0010297
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Cleft lip/palate-intestinal malrotation-cardiopathy syndrome.

View clinical trials →

No actively recruiting trials found for Cleft lip/palate-intestinal malrotation-cardiopathy syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Cleft lip/palate-intestinal malrotation-cardiopathy syndrome community →

No specialists are currently listed for Cleft lip/palate-intestinal malrotation-cardiopathy syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Cleft lip/palate-intestinal malrotation-cardiopathy syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Cleft lip/palate-intestinal malrotation-cardiopathy syndromeForum →

No community posts yet. Be the first to share your experience with Cleft lip/palate-intestinal malrotation-cardiopathy syndrome.

Start the conversation →

Latest news about Cleft lip/palate-intestinal malrotation-cardiopathy syndrome

No recent news articles for Cleft lip/palate-intestinal malrotation-cardiopathy syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Cleft lip/palate-intestinal malrotation-cardiopathy syndrome

What is Cleft lip/palate-intestinal malrotation-cardiopathy syndrome?

Cleft lip/palate-intestinal malrotation-cardiopathy syndrome (also known as Toriello-Carey syndrome) is an extremely rare congenital malformation syndrome characterized by the combination of orofacial clefting, intestinal malrotation, and cardiac defects. The condition is typically apparent at birth and affects multiple organ systems. Key clinical features include cleft lip and/or cleft palate, malrotation of the intestines (abnormal positioning of the bowel that can lead to obstruction), and congenital heart defects of variable type and severity. Additional features that have been reported in

How is Cleft lip/palate-intestinal malrotation-cardiopathy syndrome inherited?

Cleft lip/palate-intestinal malrotation-cardiopathy syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Cleft lip/palate-intestinal malrotation-cardiopathy syndrome typically begin?

Typical onset of Cleft lip/palate-intestinal malrotation-cardiopathy syndrome is neonatal. Age of onset can vary across affected individuals.